BioAtlantis Ltd., Clash Industrial Estate, Tralee, Co. Kerry, Ireland. :: Tel: +353 66 711 8477 :: Fax:+353 66 7119802 :: Click here to email us


BioAtlantis Digestica®

BioAtlantis has developed novel nutraceutical compositions designed to enhance the immunological state of the human gastrointestinal tract. Digestica®, one such product, consists of a unique composition of soluble marine algal fibres which act in synergy to enhance immune function and improve the microbial population.


Digestica® enhances immunity to infection.
Pre-clinical trials have demonstrated how Digestica® has a positive effect on immune function. In particular, consumption of Digestica® enhances immunity to infectious diseases of the gastrointestinal tract, such as E. Coli, while increasing numbers of beneficial species of gut bacteria, such as Lactobacilli and Bifidobacteria. The proven immuno-modulating and prebiotic properties of Digestica® may provide benefit to those suffering from autoimmune diseases and/or to those who wish to maximise overall gastrointestinal health.


Digestica® enhances digestion.
Pre-clinical trials demonstrate that Digestica® significantly enhances the digestion of organic matter and fibre in the mammalian gastrointestinal tract. Furthermore, significant increases in absorption of micro and macro-nutrients in the intestine are also achieved through the use of Digestica®. Thus, dietary supplementation with Digestica® provides a novel means of improving not only gut health and immunity, but also digestion.


Digestica® increases the production of short chain fatty acids.
Pre-clinical trials demonstrate that Digestica® significantly enhances the production of short chain fatty acids (butyric) while simultaneously reducing the level of branched chain fatty acids such as isovaleric and valeric.

Latest News:

BIM Seafood Capital Investment Scheme

BioAtlantis Ltd is delighted to participate in the Capital Seafood Investment Scheme which is supported by Bord Iascaigh Mhara and the European Union as part of our mission to ensure production of high value added products from Seaweed. The scheme aims to encourage innovation, enhance scale and competitiveness in industry, and provide capital investment in new technologies. http://www.bioatlantis.com/images/uploads/poster1.jpg


bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis bioatlantis